Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

Kaplan–Meier curves showed that extended adjuvant pyrotinib administered after trastuzumab-based adjuvant therapy provides a promising survival benefit in patients with high-risk HER2-positive breast ...

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

Scientists are working to create a new light-activated 'smart' bomb to treat aggressive breast cancer. The new light-sensitive chemicals called cyanine-carborane salts are used in photodynamic therapy ...

“Our innovative cyanine-carborane salts offer a targeted option with reduced side effects for patients with aggressive breast ...

Researchers sought to determine whether contemporary hormonal contraception methods are associated with risk of developing VTE.

Jim Willwerth, in this horticulture discussion, delves into hormonal therapy for grapevines, including plant growth ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.